Changing the Outlook
The median age of survival for CF patients has increased to more than 37 years – far more encouraging than the six-month life expectancy in the 50s. Along with this good news, comes the need to focus on CF patients who are living well into their adult years. With Gunnar growing into adulthood, the Esiasons have added the focus of bridging the gap between pediatric and adult CF care. With the life expectancy expanding, the research efforts have to adjust as well. Part of bridging that gap and addressing this new milestone for the disease, The Boomer Esiason Foundation granted Columbia University Medical Center $6 million to establish the Gunnar Esiason Adult Cystic Fibrosis and Lung Program in 2009.